TNF Pharmaceuticals, Inc. Gains 48.15%
Fri, Sep 26, 2025 at 08:25 PM
TNF Pharmaceuticals, Inc. (TNFA:NASDAQ) soared at $5.2, representing a gain of 48.1%. The stock appeared on our News Catalysts scanner on Wed, Sep 24, 2025 at 10:49 AM in the 'MISCELLANEOUS' category. From Mon, Sep 15, 2025, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Sep 24, 2025 at $8.9 with a volume of 60M+.
About TNF Pharmaceuticals, Inc. (TNFA:NASDAQ)
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Top 10 Gainers:
- Applied Therapeutics, Inc. (APLT:NASDAQ), 121.35%
- MEDIROM Healthcare Technologies Inc. (MRM:NASDAQ), 102.76%
- bioAffinity Technologies, Inc. (BIAF:NASDAQ), 55.13%
- Hang Feng Technology Innovation Co. Ltd. (FOFO:NASDAQ), 51.26%
- Aqua Metals, Inc. (AQMS:NASDAQ), 48.37%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Top KingWin Ltd (WAI:NASDAQ), 47.78%
- Platinum Analytics Cayman Limited (PLTS:NASDAQ), 44.3%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 42.27%
- Dragonfly Energy Holdings Corp. (DFLI:NASDAQ), 38.46%